tradingkey.logo
tradingkey.logo
Search

Sharps Technology Inc

STSS
Add to Watchlist
1.880USD
-0.120-6.00%
Close 05/15, 16:00ETQuotes delayed by 15 min
54.51MMarket Cap
LossP/E TTM

Sharps Technology Inc

1.880
-0.120-6.00%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-6.00%

5 Days

-6.00%

1 Month

-2.08%

6 Months

-38.96%

Year to Date

-7.39%

1 Year

-58.86%

Key Insights

Sharps Technology Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 161 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 22.00.In the medium term, the stock price is expected to remain stable.The company has shown average stock market performance over the past month, with weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Sharps Technology Inc's Score

Industry at a Glance

Industry Ranking
161 / 206
Overall Ranking
515 / 4482
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Sharps Technology Inc Highlights

StrengthsRisks
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Growing
The company is in a growing phase, with the latest annual income totaling USD 7.01M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 7.01M.
Fairly Valued
The company’s latest PE is -0.17, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 12.23M shares, increasing 42.03% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 20.80K shares of this stock.

Analyst Rating

Based on 0 analysts
--
Current Rating
22.000
Target Price
+877.78%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Sharps Technology Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Sharps Technology Inc Info

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Ticker SymbolSTSS
CompanySharps Technology Inc
CEOMr. Robert M. Hayes
Websitehttps://sharpstechnology.com/
KeyAI